Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ: TVGN )

1.220 +0.080 (+7.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tevogen Bio Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
From Tevogen Bio Inc
Via GlobeNewswire
Why Is Tevogen Bio (TVGN) Stock Up 54% Today?
Tevogen Bio stock is up on Monday with heavy trading of TVGN stock after securing $50 million in new financing from a current investor. 
Via InvestorPlace
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities
From Tevogen Bio Inc
Via GlobeNewswire
Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Set to Join Russell 3000® Index
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2
From Tevogen Bio Inc
Via GlobeNewswire
TVGN Stock Earnings: Tevogen Bio Holdings Reported Results for Q1 2024
Tevogen Bio Holdings just reported results for the first quarter of 2024. 
Via InvestorPlace
Tevogen Bio Reports First Quarter 2024 Financial Results
From Tevogen Bio Inc
Via GlobeNewswire
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
From Tevogen Bio Inc
Via GlobeNewswire
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Tevogen Bio Holdings Stock Is Moving Higher Today
Tevogen shares are rising Monday after the company secured up to $50 million of financing from an existing investor aimed at supporting continued research and development efforts for Tevogen's TVGN... 
Via Benzinga
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
TransCode Therapeutics stock is down on Monday after the company announced plans for a shareholder meeting for RNAZ investors. 
Via InvestorPlace
Why Is Safe & Green Development (SGD) Stock Down 5% Today?
Safe & Green Development stock is down on Monday as SGD investors learn of a Form D filing with the SEC for a securities sale. 
Via InvestorPlace
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Is AC Immune (ACIU) Stock Up 45% Today?
AC Immune stock is up on Monday after as investors in ACIU react to a new collaboration agreement with Takeda Pharmaceutical. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
From Tevogen Bio Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.